secwatch.observer — SEC 8-K summary
======================================

Issuer:     Certara, Inc. (CERT)
CIK:        0001827090
Form:       8-K
Filed at:   2025-03-05T23:59:59+00:00
Accession:  0001827090-25-000018
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Certara President Patrick F. Smith steps down, moves to senior advisory role
----------------------------------------------------------------------------

- Dr. Patrick F. Smith stepped down as President, Certara Drug Development Solutions, effective March 3, 2025.
- Smith remains employed at Certara in a senior advisory and scientific capacity.
- No replacement for the President role was announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/0001827090-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/certara-20250303.htm
  HTML page:      https://secwatch.observer/filing/0001827090-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer